Evifacotrep is a selective TRPC5 channel antagonist, referenced in patent WO2020061162. It serves as a research tool for investigating neurological disorders, with applications in both in vitro and in vivo experimental models to study TRPC5-mediated signaling pathways.
Molecular Weight:
441.77
Purity:
99.89% (May vary between batches)
CAS Number:
[2413739-88-3]
Formula:
C18H12ClF4N5O2
Target:
TRP/TRPV Channel
Application Notes:
Solubility: DMSO:55 mg/mL (124.5 mM)
* VAT and and shipping costs not included. Errors and price changes excepted